DelveInsight's "FYARRO Market Size, Forecast, and Market Insight Report" highlights the details around FYARRO, an mTOR inhibitor. The report provides product descriptions, patent details, and ...

In China, the majority of gastric cancer patients, accounting for about 80% of the total, are in the locally advanced ... Numerous clinical trials are currently exploring preoperative neoadjuvant ...

Steve Liesman, Senior CNBC Economics Reporter joins Nicolle Wallace on Deadline White House with reaction to Donald Trump temporarily halting some tariffs for the next 90 days on countries he says ...

Nivolumab plus ipilimumab is being reviewed by the FDA as a first-line treatment for advanced colorectal cancer, with a decision expected by June 2025.

Don't get it twisted: there is not a cat in the world who isn't gorgeous in their own right. Even the “ugly” ones often go viral for being so lovable. Grumpy Cat, for example, is beloved by all, and ...

Enriqueta Felip, MD, PhD, discusses the phase 3 3475A-D77 study of subcutaneous pembrolizumab plus chemotherapy in metastatic non–small cell lung cancer. Enriqueta Felip, MD, PhD, the Universitat ...

Pancreatic ductal adenocarcinoma (PDAC) frequently exhibits an abundant desmoplastic stroma, which substantially blocks the penetration of therapeutics and decreases the response to therapy. Clinical ...

5 In the AEGEAN trial, the primary endpoints were pCR, defined as no viable tumour in the resection specimen (including lymph nodes) following neoadjuvant therapy, and EFS, defined as the time from ...

Neoadjuvant chemotherapy specifically refers to chemotherapy administered before your primary treatment, which may be surgery or radiation therapy. It can help make surgery more effective or allow ...

High-risk patients were defined as those meeting one of the following criteria: N stage ≥1; T stage ≥2; absence of pathological complete response (pCR) after neoadjuvant therapy ... a dropout rate of ...